Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Symptomatic Hypertrophic Cardiomyopathy (HCM)
NCT00011076Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Feb 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing Pirfenidone with Placebo (2 arms). Started Feb 2001; status: completed.
02
Drugs
pirfenidone
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT00011076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00011076.